Veterinary Medicines

EURICAN DAPPi - LR liofilizat in suspenzija za pripravo suspenzije za injiciranje za pse

Authorised
  • Rabies virus, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, Inactivated
  • Leptospira interrogans, Serogroup Canicola, Live
  • Canine parainfluenza virus, Live
  • Canine parvovirus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Download as PDF

Product identification

Medicine name:
EURICAN DAPPi - LR liofilizat in suspenzija za pripravo suspenzije za injiciranje za pse
Active substance:
  • Rabies virus, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, Inactivated
  • Leptospira interrogans, Serogroup Canicola, Live
  • Canine parainfluenza virus, Live
  • Canine parvovirus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, Inactivated
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, Inactivated
    1.00
    European Pharmacopoeia Unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, Serogroup Canicola, Live
    1.00
    European Pharmacopoeia Unit(s)
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, Live
    50118.00
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine parvovirus, Live
    79432.00
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine adenovirus 2, Live
    316.00
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine distemper virus, Live
    10000.00
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • NP/V/0126/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 14/11/2021
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 14/11/2021
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 14/11/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."